Our previous studies have shown that atherosclerotic mice treated with anakinra or the murine version of canakinumab, as well as IL‐1R1 knockout mice, have reduced blood pressure and atherosclerosis formation compared with controls9, 81 and that this finding is replicated in our DHA‐fed mice. The gene discussed is IL1R1; the disease is atherosclerosis.